Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105651 · ClinicalTrials.gov registry record · NA
A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT00105651: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00105651 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105651, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
Data from the Surveillance, Epidemiology and End Results (SEER) cancer registry indicates that head and neck cancers (HN Ca) are nearly twice as common in veterans as non-veterans. HN Ca patients are at an increased risk for smoking, alcohol consumption and depression, all of which contribute to a further decline in their quality of life (QoL). In the HN Ca population, diagnosis and treatment of smoking, alcohol intake and depression are sub-optimal, thereby affecting QoL and survival. Numerous studies have documented that smoking, alcohol and depression are interrelated and research on multi-modal interventions has been suggested.
Interventions
- BEHAVIORAL Combined nursing invention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Est. Completion | 2004-03 |
| Phase | NA |
What the finished NCT00105651 record still lists
NCT00105651 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Combined nursing invention is the first listed.
NCT00105651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00105651 about?
NCT00105651 is a clinical study titled "A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer". Data from the Surveillance, Epidemiology and End Results (SEER) cancer registry indicates that head and neck cancers (HN Ca) are nearly twice as common in veterans as non-veterans. HN Ca patients are at an increased risk for smoking, alcohol consumption and depression, all of which contribute to a f...
What is the current status of trial NCT00105651?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00105651?
The interventions under investigation include: Combined nursing invention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00105651?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00105651's enrollment target sits among peer trials
128 744th of 2000 higher than 1,252 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD